Drugs / F-18 FPCIT
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00468078 | Nov 2006 → Sep 2007 | Parkinson disease | Asan Medical Center | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | F-18 FPCIT | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00468078 ↗ |
| Modality | Diagnostic / imaging agent | “F-18 FPCIT is a promising radiopharmaceutical for PET imaging” NCT00468078 ↗ |
| Route | Intravenous | “5mCi, intravenous injection” NCT00468078 ↗ |